 "Covaxin, bharat biotech, covid, coronavirus, vaccine, drugs, medicine, pharma")
After the country's apex health research institute tried to allay concerns over setting a hurried deadline to find India's indigenous Covid-19 vaccine candidate, it is up to clinical sites to ensure that the trials happen swiftly, but by following due process. Sites that Business Standard spoke to say that each of them might take their own time, which will depend on getting logistics right before volunteer recruitment begin.
There are 12 sites in all across India in which both private and public hospitals that are conducting phase-1 and phase-2 human clinical trials for Bharat Biotech's Covaxin.
Based on the earlier letter of
